CHM 11.1% 2.0¢ chimeric therapeutics limited

Webinar 17/06/24, page-26

  1. 823 Posts.
    lightbulb Created with Sketch. 87
    From what I heard in the interview, Rebecca's comment on scarcity of neurosurgeons was about the trials themselves, not the final product.
    Given this scarcity, the trials become not only expensive but logistically challenging to plan and conduct.
    Her feeling seems to be that CHM's limited resources are better focused on the other trials... at least for now.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.002(11.1%)
Mkt cap ! $17.25M
Open High Low Value Volume
1.9¢ 2.1¢ 1.9¢ $56.44K 2.801M

Buyers (Bids)

No. Vol. Price($)
5 1655923 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 1520755 2
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.